Chidamide, Rituximab Plus EAC Regimen with Autologous Hemopoietic Stem Cell Transplantation in High-risk and Relapsed/Refractory B-cell Lymphoma and Long Term Follow-up
Titel:
Chidamide, Rituximab Plus EAC Regimen with Autologous Hemopoietic Stem Cell Transplantation in High-risk and Relapsed/Refractory B-cell Lymphoma and Long Term Follow-up